Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Syncron AB in conjunction with the merger with Mize, Inc.
Mandate

Vinge advises Syncron AB in conjunction with the merger with Mize, Inc.

August 18, 2021 M&A

Vinge has advised Syncron in conjunction with the merger with the US company, Mize.

The merged company will be the world’s largest unlisted global actor within the industrial companies’ after-sales service industry. At present, the companies are leading actors in the cloud-based SaaS solutions on their respective markets and will conducts operations under the trademark Syncron. The company’s headquarters will be in Stockholm.

Vinge’s team primarily consisted of Johan Winnerblad, Mikael Ståhl, Carl Sander, Lionardo Ojeda and Isabelle Jengsell.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024